I love working at mission-driven companies. Verana’s deep commitment to improving patient care and accelerating scientific research with clinical data is something the entire organization is behind.
Karim Damji serves as Senior Vice President of Product at Verana Health, where he is responsible for leading product strategy and development. Karim, a product veteran with a 20-year track record of success, has launched some of the most notable solutions in healthcare and technology. He most recently led product, technology and marketing at Saama, where he launched solutions for the life science industry including the award-winning Life Science Analytics Cloud. Prior to Saama, Karim led software strategy and product at Plantronics. He also served in leadership positions spanning business development, product management, sales, and network engineering at Cisco, and as founding head of product at Vocera Communications, MobileIron and DiVitas.
Karim earned his Bachelor’s degree in computational and applied mathematics from San Jose State University.Karim Damji on LinkedIn
At Verana, I’ve found a team that I believe is going to revolutionize healthcare with data. It is refreshing and deeply gratifying to work with people who are so purpose-driven.
Hylton Kalvaria is Senior Vice President of Commercial and Strategic Partnerships, leading Verana’s commercial organization, marketing, and major partnership initiatives with medical associations, life science companies, and regulatory bodies. Hylton joins Verana from Flatiron Health, where he founded, built and led the West Coast business, representing half of Flatiron’s commercial activity. In that capacity, Hylton’s team led the design and execution of Flatiron’s first regulatory-grade projects intended for influential stakeholder audiences, including the FDA. Hylton previously held a variety of roles at Genentech and was appointed to lead a CEO-sponsored initiative focused on identifying emerging sources of real-world data and utilizing those data across the Genentech organization, an initiative that led to Roche’s initial investment in Flatiron.
Hylton holds an MBA and BS in Economics from Duke University.Hylton Kalvaria on LinkedIn
I'm excited to make a big impact on how we generate evidence for new and existing drugs and devices. We have an opportunity to reinvent that process to be more patient and provider focused.
Marie-Eve Piche, Verana’s Chief Financial Officer, has nearly two decades of financial management experience in public and fast-growing private companies. Marie-Eve was previously the CFO of Pymetrics and built the financial strategy and capabilities that enabled a successful Series B fundraising. She also served as Vice President of Financial Planning and Analysis at AppNexus, where she helped grow revenue by more than six times during her tenure and was on the team that drove the $1.6B acquisition by AT&T. She began her career at General Electric, holding key financial roles at NBC Sports and Telemundo.
Marie-Eve received her dual MBA from Columbia University and London Business School. She also holds a Master’s in economics from McGill University and a B.Com. from H.E.C. Montreal.Marie-Eve Piche on LinkedIn
Verana Health is a company that is doing ground-breaking work with technology and data, and is being built by a team that works tirelessly to deliver against its commitment to patients. I'm thrilled to contribute to the impact I know this company will make.
Matthew Roe, MD, MHS is Chief Medical Officer at Verana Health, where he leads the cross therapeutic medical team working to ensure the clinical validity and scientific integrity of the company’s research. Additionally, Dr. Roe leads Verana’s regulatory strategy, which focuses on determining how data curated by Verana can be utilized for regulatory decision-making. A cardiologist and clinical researcher, Dr. Roe joined Verana after spending two decades at the Duke University School of Medicine and the Duke Clinical Research Institute (DCRI), the world’s largest academic research organization. At Duke, he focused on research initiatives leveraging real-world data for observational and prospective studies. Dr. Roe was previously a co-principal investigator for the landmark ADAPTABLE trial and also held leadership positions with several diverse registries focusing upon the treatment and outcomes of patients with cardiovascular disease. At the DCRI, Dr. Roe was Senior Investigator as well as the Director of the organization’s Clinical Research Fellowship and Think Tank series.
Dr. Roe received his MD and MHS degrees from Duke University School of Medicine in 1993 and 2001, respectively. He completed an Internal Medicine residency at Duke University Medical Center in 1996 and a Cardiovascular Fellowship at the Cleveland Clinic Foundation in 1999.Matthew Roe, MD, MHS on LinkedIn
I joined Verana Health to contribute to our mission of leveraging real-world data to enable clinicians to provide the highest quality medical care, to improve the health and quality of life of patients across diverse medical conditions, and to catalyze a transformation of clinical research approaches and processes.
Don Butler brings several decades of sales and business leadership experience to Verana Health, where he serves as Vice President, Commercial. Don joins Verana from Outcome Health, where he served as Senior Vice President of Clinical Research Solutions. Prior to Outcome Health, Don was Senior Vice President of Global Enterprise Sales at Medidata Solutions, where he led the global sales team responsible for selling clinical and data analytics solutions that support over half of the world’s clinical trials. He previously held sales leadership roles for Oracle Health Sciences and Siebel Life Sciences.
Don holds a Bachelor’s degree in business from Ithaca College and is an alumnus of Harvard Business School’s extensive executive education program.Don Butler on LinkedIn
My career is inspired by the clinical trial that saved my mother’s life from stage 4 ovarian cancer. Verana gives me the opportunity to help connect patients with clinical trials that can improve and save their lives.
Kerry Foster is Vice President, Interim General Counsel and Privacy Officer at Verana Health, where she is responsible for all of the company’s legal functions, including corporate governance, privacy and compliance, commercial contracting, intellectual property activities, and risk management. Kerry has a unique combination of sophisticated legal experience and business acumen honed through over 15 years of experience in healthcare. Prior to joining Verana, Kerry advised national healthcare companies, hospitals, physician groups, and private equity funds on transactional, corporate and healthcare regulatory matters as a Senior Associate at DLA Piper LLP. Kerry has also held various operational positions at large health systems.
Kerry received a JD from the University of Miami School of Law, a MS in Health Systems Management from George Mason University, and a BS in Healthcare Management and Business Administration from Towson University.Kerry Foster on LinkedIn
I’ve spent my entire career in healthcare and I have always been drawn to organizations that seek to make a difference in people’s lives. Verana’s pursuit of accelerating research for patients through innovative technology is a mission I wanted to be a part of.
Nader Halim is Vice President of Strategy at Verana Health, where he is responsible for the strategic direction of Verana’s clinical trials business and other corporate strategy projects. Nader brings over 20 years of experience in the life sciences industry, including academic research, policy, research and development, and consulting. Most recently, Nader was Senior Director of Emerging Science and Innovation at Pfizer where he led global policy and international public affairs. Prior to Pfizer, Nader led commercial development initiatives at Genentech as Senior Manager of Commercial Assessments, Market Analysis and Strategy. He previously held consulting leadership roles at Quintiles Consulting and Avalere Health, where he consulted in all areas of life science with a focus on pharmaceuticals, devices, and diagnostics.
Nader received his PhD in Molecular and Cell Biology from the Uniformed Services University of the Health Sciences. He also holds a dual MBA and MPH from Johns Hopkins and a Bachelor’s degree in biology from San Diego State University.Nader Halim, PhD on LinkedIn
At Verana, we have a real opportunity to leverage big data to better inform clinical decision making, improve the efficiency of research and clinical trials, and impact patient lives.
Vishal Malik is Vice President of Engineering and Data Analytics, where he is responsible for leading engineering and data analytics at Verana Health. Vishal’s recent work as Cofounder and CTO of an AI startup focused on building deep learning platforms for domains like drug discovery and small molecule discovery based on big data pipelines. He comes from a background in deep learning, drug discovery, big data pipelines and predictive analytics coupled with virtualization and high-performance storage systems. He thrives on analyzing hard problems, working through ambiguity to deliver solutions that have the highest business impact. Vishal is a hands-on technologist who has conceptualized and delivered computational storage products with multi-million dollar business value. Prior to that, he was the CTO, US region at Cognizant where he built big data pipeline platforms for data insights, analytics and drug discovery. His past accomplishments include building highly scalable systems at Hewlett Packard Company and VBune, Inc.
Vishal holds a B.S and M.S from Georgian Technical University.Vishal Malik on LinkedIn
I am really passionate about building systems and products that have real-world impact and change human lives for the better. Verana Health’s mission to accelerate medical research and improve patient care is what I have always wanted to be part of and contribute to its success. Ingesting, curating large datasets and using it to advance medical research is a lifetime opportunity at Verana that is very fulfilling.
Chhaya Shadra is Vice President of Product Management, Data & Informatics, where she is responsible for leading product vision and strategy for data and informatics at Verana Health. Chhaya is an epidemiologist-informatician by training, bringing her deep understanding of systems engineering and user workflow to healthcare technology companies like Converge Health by Deloitte, Humedica by Optum, Syapse, Flatiron Health, and Verana Health. Chhaya’s recent work has focused on product, information architecture and ontology development for integrated precision research data platforms that are sourced from EHR, claims, pharmacy, and medical device data. These platforms are currently being used for real-world observational research, health economics and outcomes research (HEOR), and comparative effectiveness research (CER). Chhaya has focused her informatics career on interoperability and data integrity of routinely captured data that may be used secondarily.
Chhaya holds a Master’s in Health Informatics from Northeastern University and a Master’s in Health Sciences in Epidemiology from Pune University.Chhaya Shadra on LinkedIn
I’m passionate about innovation and outside the box thinking in healthcare. We have been following the same paradigms of research and evidence generation in healthcare for over half a century, even with the backdrop of technological innovation and vast amounts of data being captured for routine care. Verana’s mission of curating the largest sets of routinely captured specialty data in medicine to accelerate clinical research for the patient is exactly aligned with my personal passion and mission.
Nikolai Steklov is Vice President of Product Management and Design, where he leads the development of innovative product solutions for physicians and healthcare systems. Nikolai comes from a background of medical device development and healthcare mobile technology across specialties in the healthcare industry, including orthopaedics, oncology, and speech pathology. His past accomplishments include research and development of smart orthopaedic implants and robotic tissue engineering systems at Scripps Clinic and The Scripps Research Institute. At Digisight Technologies, he launched an integrated teleophthalmology platform and a remote patient monitoring application. Nikolai is passionate about bringing technological advancements to the healthcare field to accelerate innovation and make a meaningful impact on global health and wellbeing of people.
Nikolai holds a B.S. in bioengineering from the University of California San Diego.Nikolai Steklov on LinkedIn
I am excited to be part of the most innovative vision in healthcare, and to work with individuals equally passionate about making a positive impact on the world. Verana is poised to transform the healthcare industry through unprecedented insights into patient health on a global scale.
Ritu Tandon is Director of Marketing at Verana Health and leads all marketing and strategic communication initiatives. She has dedicated her career to scaling innovation and expanding access within health care and education, and has experience leading all aspects of new product launch. Prior to Verana, Ritu served as the first Program Director for the 49ers STEM Leadership Institute, where she also spearheaded the team that launched the Learning Innovation Hub, a program that connects education technology entrepreneurs with Silicon Valley educators. Ritu was selected as a New Sector Alliance Americorps Fellow and an Education Pioneers Fellow.
Ritu earned her Bachelor’s degree in Biology from MIT and holds an MA in Education Policy, Organization, and Leadership Studies from Stanford.Ritu Tandon on LinkedIn
Research drives medical innovation and decision-making. At Verana, I get to be part of a team that will help patients access the best care possible more quickly than ever before by reimagining how medical research happens with real-world data.
Brian Worley is Vice President of Provider Analytics, leading Verana Health’s efforts to enable the collection and analysis of the data from clinical data registries. Prior to joining Verana Health, Brian was co-founder and CEO of PYA Analytics, a data analytics company focused on ingestion and analyses of disparate data at a scale that specialized in healthcare data research. Previously, Brian was the Data Science Research Director at Oak Ridge National Laboratory, where he oversaw federal research in large-scale data architectures, data analytics, discrete-event simulations, geo-spatial sciences, cybersecurity, and quantum sciences.
Brian holds a PhD in nuclear engineering from the Massachusetts Institute of Technology.Brian Worley, PhD on LinkedIn
I am excited to have a chance to impact some of the most pressing societal health problems, such as blindness and multiple sclerosis, through the application of innovative data science on real-world data. Being at the frontier of future technologies enabled by data and collaborating with the workforce of tomorrow is exhilarating.
Sonja Wustrack is Vice President, Commercial at Verana Health, where she brings over 20 years of health research experience, including academic research, public health surveillance, clinical trial technology, and clinical research. Within the biotechnology and pharmaceutical space, she has held positions in delivery, operations management, sales enablement leadership and account management. Most recently at IQVIA, Sonja focused on enhancing customer engagement and demonstrating improved value through for pharma, payors, providers and patients by leveraging real-world data and analytics to innovate clinical trial design and accelerate execution.
Sonja holds an MPH in Epidemiology from the Tulane School of Public Health, and a Bachelor’s degree in biology from Vassar College.Sonja Wustrack on LinkedIn
I am inspired by the mission to get the right medicines to patients, faster. At Verana, we have an unparalleled depth of real-world data, combined with the expert data insights and clinical expertise and supported by technology and advanced analytics, to be a partner in shifting the drug development paradigm by enabling acceleration through innovation.
Kleiner, Perkins, Caufield & Byers
Verana Health and Lagunita Biosciences
Chief Executive Officer,
American Academy of Ophthalmology
Ahmanson Professor in Ophthalmology,
Stein Eye Institute, UCLA
Chief Executive Officer,
American Urological Association
American Academy of Neurology
Co-Founder and Managing Director,
Biomatics Capital Partners
Chief Investment Officer and Founder,
Verana Health is backed by leading institutional investors and industry veterans:
Brook Byers, founding member and senior partner of Kleiner, Perkins, Caufield, and Byers.